ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Surajit Karmakar, Subhasree Roy Choudhury, Naren Lal Banik, Swapan Kumar Ray
Cancers are characterized by deregulation of multiple signaling pathways and thus monotherapies are hardly effective. Neuroblastoma, which often occurs in adrenal glands, is the most common childhood malignancy. Malignant neuroblastoma resists traditional tre…
Didier Dequanter, Philippe Lothaire
Introduction: To investigate the possible role of sentinel lymph node biopsy (SLNB) to upstage the N0 neck in patients with oral and oropharyngeal squamous cell carcinoma. Methods: Patients with T1-T2 oral and oropharyngeal squamous cell carcinoma accessible…
Raymond Andrew Dieter Jr., George Kuzycz, Raymond Andrew Dieter III, Robert Sean Dieter
Purpose: The development of malignancy is a life changing concern for many individuals. The classification of the tumor alone does not adequately take into consideration the patient’s physical condition. Thus, a system to classify both the patient and the tum…
Ajay P. Sandhu, Karen Messer, Mark M. Fuster, Lyudmilla Bazhenova, Ehatsham Ahmad, Minya Pu, Polly Nobiensky, Stephen Seagren
Purpose: We report our single-institution experience using hypofractionated radiotherapy in a patient population 75 years and older diagnosed with stage IA or IB (T1/T2 N0) Non-Small Cell Lung Carcinoma. Materials and methods: This is a single-institution, re…
Deniz Taştemir, Osman Demirhan, Emel Gürkan, Erdal Tunç, Nihal İnandıklıoğlu
Fluorescence in situ hybridization (FISH) has become an important tool both for defining initial chromosomal abnormalities within a disease process, and for monitoring response to therapy as well as minimal residual disease. We report the results of interphas…
Michiyo Ando, Tatsuya Morita, Akira Oshima
The aim of the study was to investigate the potential of Reminiscence Cognitive Behavior Therapy (RCBT) for improvement of spiritual well-being and self-esteem in patients. Five patients received the therapy over three sessions. The patients received RCBT con…
Shin-ichiro Kishimoto, Toshihiro Akisue, Kenta Kishimoto, Hitomi Hara, Masaya Imabori, Yoshiyuki Okada, Naomasa Fukase, Teruya Kawamoto, Ikuo Fujita, Takuya Fujimoto, Masahiro Kurosaka
Sphingolipids are ubiquitous components of cell membranes. Their metabolites ceramide, sphingosine, and sphingosine-1-phosphate (S1P) have important physiological functions, including regulation of cell growth and survival. S1P is generated by phosphorylation…
Minia Hellan, Michelle S. Gentile, Luay Ailabouni, George I. Salti
Background: Sentinel lymph node biopsy is widely used in the management of melanoma patients. Multiple markers are used to stain sentinel lymph node tissue including S100, HMB-45 and melan A with different success. We investigated, for the first time, the use…
Lucia Raimondo, Chiara Alessandra Cella, Roberto Moretto, Elide Matano, Chiara Carlomagno
Digital ischemia is a rare paraneoplastic phenomenon associated with various malignancies, especially adenocarcinomas. We reported a case of digital ischemia onset during treatment with capecitabine + oxaliplatin, letrozole and epoetinbeta in a 75-year old wo…
Mustafa Türk, Gülten Kahraman, Sevda A. Khalilova, Zakir M. O. Rzayev, Serpil Oguztüzün
Novel bioengineering functional organoboron polymers were synthesized by 1) amidolysis of poly(acrcylic acid) (PAA) with 2-aminoethyldiphenyl borinate (2-AEPB), 2) esterification of organoboron PAA polymer (PAA-B) with a-hydroxy-methoxypoly(ethylene oxide) (P…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).